Avandia Approval: FDA’s Drug-Safety Protection in Doubt

Five days before a 2007 article in the New England Journal of Medicine showed that the diabetes drug Avandia was linked to a 43% increase in heart attacks compared with other medications or placebos, a group of scientists and executives from the drug’s maker, GlaxoSmithKline , gathered in a conference room at the offices of the Food and Drug Administration in White Oak, Md. The GSK goal: to convince regulators that the evidence that the company’s $3 billion-a-year blockbuster drug caused heart problems was inconclusive.

Share

Avenging bin Laden: Taliban Unleash Spring Offensive in Afghanistan

Taliban fighters carried out a series of coordinated attacks across the embattled southern Afghan city of Kandahar Saturday — a campaign that Afghan President Hamid Karzai characterized as “revenge” for the death of Osama bin Laden. Insurgents first assaulted the provincial governor’s palace with rocket propelled grenades and small arms fire and then launched a series of strikes across the city on the headquarters of the Afghan National Police and the Transportation Police, on Police Sub-station One as well as various other Afghan National Security Force and International Security and Assistance Force buildings in both Kandahar city and in the Arghandab River Valley, ISAF reported.

Share

Bahrain: Is a U.S. Ally Using Torture to Put Down Dissent?

On March 17, Ibrahim Shareef, the head of the anti-government activist movement Waad, was snatched from his home at gunpoint by what his family describes as Bahraini security forces. Thrown into a waiting sport utility vehicle, he was driven off into the night.

Share